JHBP (CY) Holdings Limited Stock Hong Kong S.E.
Equities
6998
KYG6501A1013
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | 15.93M 2.2M 17.19M | Capitalization | 1.17B 162M 1.27B |
---|---|---|---|---|---|
Net income 2021 | -865M -120M -933M | Net income 2022 | -730M -101M -788M | EV / Sales 2021 | - |
Net cash position 2021 | 2.14B 296M 2.31B | Net cash position 2022 | 1.56B 216M 1.68B | EV / Sales 2022 | -24.3 x |
P/E ratio 2021 |
-3.28
x | P/E ratio 2022 |
-1.62
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 66.07% |
1st Jan change | Capi. | |
---|---|---|
+5.66% | 111B | |
+11.23% | 105B | |
-0.38% | 21.93B | |
-12.15% | 22.34B | |
-7.66% | 18.59B | |
-36.52% | 18.12B | |
-10.09% | 16.96B | |
+3.33% | 13.7B | |
+36.58% | 12.45B |